Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease

Multiple myeloma bone disease is characterized by an uncoupling of bone remodeling in the multiple myeloma microenvironment, resulting in the development of lytic bone lesions. Most myeloma patients suffer from these bone lesions, which not only cause morbidity but also negatively impact survival. T...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Haematologica
Auteurs principaux: Muller, Joséphine, Bolomsky, Arnold, Dubois, Sophie, Duray, Elodie, Stangelberger, Kathrin, Plougonven, Erwan, Lejeune, Margaux, Léonard, Angélique, Marty, Caroline, Hempel, Ute, Baron, Frédéric, Beguin, Yves, Cohen-Solal, Martine, Ludwig, Heinz, Heusschen, Roy, Caers, Jo
Format: Artigo
Langue:Inglês
Publié: Ferrata Storti Foundation 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6068043/
https://ncbi.nlm.nih.gov/pubmed/29748441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.185397
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires